Search research articles
Contact Us
Filters
Showing results (391-400 of 527) with videos related to
Page
of 53
Sort By:
Journal of Gastroenterology and Hepatology
|
July 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B
Tyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, et al.
Hepatology International
|
May 28, 2016
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
Masao Omata, Tatsuo Kanda, Lai Wei, et al.
Journal of Gastroenterology and Hepatology
|
July 8, 2026
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported Outcomes
George Papatheodoridis, Maria Buti, Yusuf Yilmaz, et al.
Oncotarget
|
February 5, 2017
Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International
|
May 1, 2016
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata, Tatsuo Kanda, Lai Wei, et al.
Hepatology International
|
December 13, 2018
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
Tatsuo Kanda, George K K Lau, Lai Wei, et al.
Oncotarget
|
August 20, 2016
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy
Ming-Ying Lu, Ching-I Huang, Ming-Yen Hsieh, et al.
Medicine
|
June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
Pei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
World Journal of Gastroenterology
|
March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.
Journal of Viral Hepatitis
|
August 29, 2022
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
Zobair M Younossi, Ming-Lung Yu, Mohamed El-Kassas, et al.
Page
of 53
Search research articles
Search
Showing results (391-400 of 527) with videos related to
Sort By:
Page
of 53
Journal of Gastroenterology and Hepatology
|
July 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B
Tyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, et al.
Hepatology International
|
May 28, 2016
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
Masao Omata, Tatsuo Kanda, Lai Wei, et al.
Journal of Gastroenterology and Hepatology
|
July 8, 2026
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported Outcomes
George Papatheodoridis, Maria Buti, Yusuf Yilmaz, et al.
Oncotarget
|
February 5, 2017
Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International
|
May 1, 2016
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata, Tatsuo Kanda, Lai Wei, et al.
Hepatology International
|
December 13, 2018
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
Tatsuo Kanda, George K K Lau, Lai Wei, et al.
Oncotarget
|
August 20, 2016
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy
Ming-Ying Lu, Ching-I Huang, Ming-Yen Hsieh, et al.
Medicine
|
June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
Pei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
World Journal of Gastroenterology
|
March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.
Journal of Viral Hepatitis
|
August 29, 2022
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
Zobair M Younossi, Ming-Lung Yu, Mohamed El-Kassas, et al.
Page
of 53